Book
Bottle of lies : the inside story of the generic drug boom / Katherine Eban.
Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban's Bottle of Lies exposes the deceit behind generic-drug manufacturing--and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?" -- Amazon.com
Record details
- ISBN: 9780062338785
- ISBN: 0062338781
- ISBN: 9780062338792
- ISBN: 006233879X
- Physical Description: xxiv, 482 pages ; 24 cm
- Edition: First edition.
- Publisher: New York, NY : Ecco, an imprint of HarperCollins Publishers, [2019]
- Copyright: ©2019
Content descriptions
| Bibliography, etc. Note: | Includes bibliographical references (pages [421]-461) and index. |
Search for related items by subject
| Subject: | Generic drugs > Quality control. Drug adulteration. Pharmaceutical industry > Corrupt practices > United States. |
Available copies
- 2 of 2 copies available at York County Libraries.
Holds
- 0 current holds with 2 total copies.
Other Formats and Editions
Show Only Available Copies
| Location | Call Number / Copy Notes | Barcode | Shelving Location | Status | Due Date |
|---|---|---|---|---|---|
| Kreutz Creek Valley Library | Adults 615.1 EBA Nonfiction (Text) | 34261000525830 | Adult Area | Available | - |
| Martin Library | Adults 615.1 EBA Health Wellness (Text) | 33454005676507 | 2nd Floor | Available | - |
| LDR | 02998cam a2200433 i 4500 | ||
|---|---|---|---|
| 001 | 9103151 | ||
| 003 | True | ||
| 005 | 20200128171902.0 | ||
| 008 | 181024t20192019nyu b 001 0 eng | ||
| 010 | . | ‡a 2018048368 | |
| 019 | . | ‡a1089732490 | |
| 020 | . | ‡a9780062338785 ‡q(hardback) | |
| 020 | . | ‡a0062338781 ‡q(hardback) | |
| 020 | . | ‡a9780062338792 | |
| 020 | . | ‡a006233879X | |
| 035 | . | ‡a(OCoLC)1057377213 ‡z(OCoLC)1089732490 | |
| 037 | . | ‡bHarpercollins, 53 Glenmaura National Blvd Ste 300, Moosaic, PA, USA, 18507-2132 ‡nSAN 200-2086 | |
| 040 | . | ‡aDLC ‡beng ‡erda ‡cDLC ‡dOCLCO ‡dBDX ‡dOCLCF ‡dMLY ‡dJNE ‡dKYC ‡dUAP ‡dGO3 ‡dSLV ‡dZGR ‡dYDX ‡dOCLCO ‡dGZD ‡dUtOrBLW | |
| 042 | . | ‡apcc | |
| 043 | . | ‡an-us--- | |
| 049 | . | ‡aGZDA ‡lbajc* | |
| 082 | 0 | 0. | ‡a615.1 ‡223 |
| 092 | . | ‡a615.1 ‡bE151 | |
| 092 | 0 | . | ‡a615.1 ‡bEBA |
| 100 | 1 | . | ‡aEban, Katherine, ‡eauthor. ‡0(True)308511 |
| 245 | 1 | 0. | ‡aBottle of lies : ‡bthe inside story of the generic drug boom / ‡cKatherine Eban. |
| 250 | . | ‡aFirst edition. | |
| 264 | 1. | ‡aNew York, NY : ‡bEcco, an imprint of HarperCollins Publishers, ‡c[2019] | |
| 264 | 4. | ‡c©2019 | |
| 300 | . | ‡axxiv, 482 pages ; ‡c24 cm | |
| 336 | . | ‡atext ‡btxt ‡2rdacontent | |
| 337 | . | ‡aunmediated ‡bn ‡2rdamedia | |
| 338 | . | ‡avolume ‡bnc ‡2rdacarrier | |
| 504 | . | ‡aIncludes bibliographical references (pages [421]-461) and index. | |
| 520 | . | ‡aMany have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban's Bottle of Lies exposes the deceit behind generic-drug manufacturing--and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?" -- Amazon.com | |
| 650 | 0. | ‡aGeneric drugs ‡xQuality control. | |
| 650 | 0. | ‡aDrug adulteration. ‡0(True)622471 | |
| 650 | 0. | ‡aPharmaceutical industry ‡xCorrupt practices ‡zUnited States. | |
| 901 | . | ‡a9103151 ‡bTrue ‡c9103151 ‡tbiblio ‡soclc | |
